|
1
|
Nicoli TK, Saat R, Kontio R, Piippo A,
Tarkkanen M, Tarkkanen J and Jero J: Multidisciplinary approach to
management of temporal bone giant cell tumor. J Neurol Surg Rep.
77:144–149. 2016. View Article : Google Scholar
|
|
2
|
Hu P, Zhao L, Zhang H, Yu X, Wang Z, Ye Z,
Wu S, Guo S, Zhang G, Wang J, et al: Recurrence rates and risk
factors for primary giant cell tumors around the knee: A
multicentre retrospective study in China. Sci Rep. 6:363322016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gong HS, Liu GJ, Huang QS, Chen FH and
Zhao HB: Surgical management of sacrococcygeal region giant tumors
by use of balloon occlusion abdominal aorta. Turk Neurosurg.
26:904–911. 2016.PubMed/NCBI
|
|
4
|
Dabak N, Göçer H and Çıraklı A: Advantages
of pressurized-spray cryosurgery in giant cell tumors of the bone.
Balkan Med J. 33:496–503. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rekhi B, Verma V, Gulia A, Jambhekar NA,
Desai S, Juvekar SL, Bajpai J and Puri A: Clinicopathological
features of a series of 27 cases of post-denosumab treated giant
cell tumors of bones: A single institutional experience at a
tertiary cancer referral centre, India. Pathol Oncol Res.
23:157–164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parra-Herran C1, Schoolmeester JK, Yuan L,
Dal Cin P, Fletcher CD, Quade BJ and Nucci MR: Myxoid
leiomyosarcoma of the uterus: A clinicopathologic analysis of 30
cases and review of the literature with reappraisal of its
distinction from other uterine myxoid mesenchymal neoplasms. Am J
Surg Pathol. 40:285–301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang L, Zheng Z, Zhou Q, Bai X, Fan L,
Yang C, Su L and Hu D: miR-155 promotes cutaneous wound healing
through enhanced keratinocytes migration by MMP-2. J Mol Histol.
48:147–155. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Adhikari N, Mukherjee A, Saha A and Jha T:
Arylsulfonamides and selectivity of matrix metalloproteinase-2: An
overview. Eur J Med Chem. 129:72–109. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rother S, Samsonov SA, Moeller S,
Schnabelrauch M, Rademann J, Blaszkiewicz J, Köhling S,
Waltenberger J, Pisabarro MT, Scharnweber D and Hintze V: Sulfate
hyaluronan alters endothelial cell activation in vitro by
controlling the biological activity of the angiogenic factors
vascular endothelial growth factor-A and tissue inhibitor of
metalloproteinase-3. ACS Appl Mater Interfaces. 9:9539–9550. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shooshtarizadeh T, Rahimi M and
Movahedinia S: P63 expression as a biomarker discriminating giant
cell tumor of bone from other giant cell-rich bone lesions. Pathol
Res Pract. 212:876–879. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qi DW, Wang P, Ye ZM, Yu XC, Hu YC, Zhang
GC, Yan XB, Zheng K, Zhao LM and Zhang HL: Clinical and
radiographic results of reconstruction with fibular autograft for
distal radius Giant Cell Tumor. Orthop Surg. 8:196–204. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu Y, Zhao L, Zhang H, Yu X, Wang Z, Ye Z,
Wu S, Guo S, Zhang G, Wang J and Ning X: Sex differences in the
recurrence rate and risk factors for primary giant cell tumors
around the knee in China. Sci Rep. 6:281732016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pujani M, Bahadur S, Jairajpuri ZS, Jetley
S and Jameel J: Giant cell tumor bone in an elderly male - an
unusual case misdiagnosed on MRI as a malignant sarcoma. Indian J
Surg Oncol. 6:285–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Almalki SG, Valle Llamas Y and Agrawal DK:
MMP-2 and MMP-14 silencing inhibits VEGFR2 cleavage and induces the
differentiation of porcine adipose-derived mesenchymal stem cells
to endothelial cells. Stem Cells Transl Med. 6:1385–1398. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yadav PK, Yadav BS, Panigrahi PN, Tripathi
V, Chaturvedi N and Kataria M: Molecular characterization and
in-silico analysis of the tissue inhibitor of metalloproteinases-3
(TIMP-3) gene of canine mammary tumor. Comb Chem High Throughput
Screen. 60:686–691. 2017.
|
|
16
|
Su CW, Su BF, Chiang WL, Yang SF, Chen MK
and Lin CW: Plasma levels of the tissue inhibitor matrix
metalloproteinase-3 as a potential biomarker in oral cancer
progression. Int J Med Sci. 14:37–44. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sharma K, Tyagi R, Singh R, Sharma SK and
Anand A: Serum levels of TIMP-3, LIPC, IER3 and SLC16A8 in CFH
negative AMD cases. J Cell Biochem. 118:2087–2095. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin HF, Hsi E, Huang LC, Liao YC, Juo SH
and Lin RT: Methylation in the matrix metalloproteinase-2 gene is
associated with cerebral ischemic stroke. J Investig Med.
65:794–799. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pillai SS, Yukawa H, Onoshima D, Biju V
and Baba Y: Förster resonance energy transfer mediated
photoluminescence quenching in stoichiometrically assembled
CdSe/ZnS quantum dot-peptide labeled black hole quencher conjugates
for matrix metalloproteinase-2 sensing. Anal Sci. 33:137–142. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu D, Zhang R, Wu J, Pu Y, Yin X, Cheng
Y, Wu J, Feng C, Luo Y and Zhang J: Interleukin-17A promotes
esophageal adenocarcinoma cell invasiveness through ROS-dependent,
NF-κB-mediated MMP-2/9 activation. Oncol Rep. 37:1779–1785. 2017.
View Article : Google Scholar : PubMed/NCBI
|
